| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |